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Background: More than 170 million adults use dietary supplements (DSs) in the United States, 
which can have both benefit and harm to patient health. DS use is often poorly documented in 
the medical record and can pose health risks if not properly communicated with providers. 
Reasons for poor DS documentation include low disclosure rates, time constraints of clinical 
encounters, and providers’ failure to inquire about DS use. This study was conducted to assess 
patients’ views on the facilitators and barriers to using a mobile health (mHealth) application 
(app) to collect and share DS information with their healthcare providers.  
Methods: Utilizing a theory-based conceptual model, we conducted seven patient focus groups 
(FGs) to assess opinions on DS safety, provider communication, comfort with technology use, and 
our proposed mHealth app. Patient views will inform the creation of an mHealth app to improve 
DS patient-provider communication and tracking and reconciliation in the electronic medical 
record (EMR).  
Results: Overall, participants believe their DS information is inaccurately represented in the EMR 
leading to safety concerns and negatively impacting overall quality-of-care. Participants desired 
an app designed with: 1) Health Insurance Portability and Accountability Act (HIPAA)-compliance; 
2) ease of use for a variety of technical efficacy levels; 3) access to reliable DS information, 
including a DS-drug interaction checker; 4) integration with the EMR. 
Conclusion: An app to simplify and improve DS entry and reconciliation was of interest to 




In the United States, dietary supplements (DSs) are widely used, especially among 
patients with acute and chronic illnesses [1-3]. DS use is highly prevalent among cancer survivors 
(70.4%) [4], ranging from 70% in breast cancer [5] to 85% in gynecologic cancer [6], as well as 
multiple chronic conditions (50%) [7] including hypercholesterolemia (30%), hypertension (28%), 
and diabetes (25%) [8]. Furthermore, concomitant use of DSs with prescription medications is 
common, ranging from 34% in all age groups [9] to 66% among older adults [10]. In patients with 
chronic disease, who often take multiple prescription medications, some supplements are unsafe 
due to supplement-drug interactions (SDI) [11-13].  
DSs are often presumed by patients to have a low potential for harm, contributing to low 
rates of disclosure in medical encounters [14]. DS manufacturers are not required to submit safety 
and efficacy data to the Food and Drug Administration (FDA) prior to marketing, and quality 
control can vary widely among manufacturers; therefore, patients’ perceptions of safety may be 
misplaced. Problematic DS products are recalled via voluntary post-marketing reporting, but the 
FDA estimates they are notified of <1% of adverse effects associated with DS use [15-17]. 
Additionally, DSs can have important interactions with prescription medications [18]. Despite 
recommendations by both the Joint Commission and the American Society of Health-System 
Pharmacists, many health systems lack policies regarding DS use and monitoring [19]. 
 Documentation of DS use may be poor for several reasons including: 1) low rates of 
disclosure by patients [20-21], 2) time-sensitive nature of clinical encounters [22], and 3) providers 
not asking or supporting DS use [21]. For example, a study of hospitalized patients at a tertiary 
center found only 6% of DS users were asked, had disclosed, and had documentation of DS use in 
the electronic medical record (EMR) during their inpatient stay [20]. Another study found 49% of 
DS users discussed at least one supplement with their provider but disclosed only 34% of total DS 
products used [21]. Two studies of hospitalized patients found that physicians inquired about DS 
use roughly 20% of the time [18, 20]. Reasons for lack of inquiry include short clinical encounters 
and the multidisciplinary approach to reconciliation creating confusion on role responsibility [20-
22]. Poor DS documentation and patient-provider communication impedes identification of 
important medication safety issues such as SDIs, DS-disease interactions, adverse events, and 
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overdosing [20-21, 23]. New methods are needed to simplify and improve the process of DS 
tracking and reconciliation.  
A mobile health technology (mHealth) application (app) could facilitate entry of medical 
information into the EMR [24]. For example, barcode scanning of DS products could reduce the 
time and errors associated with manual data entry. Additionally, a current and accurate list of DS 
products may encourage patient-provider communications about supplements [24]. The app would 
be useful for organizing key DS information, including brand name, ingredients, and 
recommended dose, to communicate with providers.  
This qualitative study aimed to interview patients via focus groups (FGs), collect and 
analyze their responses, and describe patients’ perceptions on the safety and risk associated with 
DS use and their experience of DS tracking and reconciliation, as well as their views on using an 
mHealth app to collect and share DS information with their healthcare providers. Patient input will 
inform the creation of an mHealth app that will collect DS information in a way that is congruent 
with patient’s needs and desires, and that will facilitate improved communication about DS use 
with their healthcare providers. The study takes into consideration existing mHealth apps along 
with their strengths and deficiencies. 
Methods  
Study Design and Conceptual Model  
We conducted a qualitative FG study using an applied social anthropology approach to 
create a conceptual model (Fig. 1) [25]. FGs were conducted in person or via a secure 
teleconference interface. Data collection continued until we reached data saturation. This study 
was approved by the Institutional Review Board. 
Conceptual Model 
Our conceptual model (Fig. 1) identified key constructs that aimed to predict a person’s 
intention to use our DS mHealth app. Our model was based on the Unified Technology 
Acceptance and Use of Technology (UTAUT) model, a popular model for evaluating consumer 
technology usage behavior that is based on four key constructs: performance expectancy, effort 
expectancy, social influence, and facilitating factors [26-27]. Because proposed users of our app 
will be adopting both technology and health improvement behavior, we enriched the model with 
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health behavior theories, including the Health Belief Model (Perceived Threat and Benefits), the 
Theory of Planned Behavior (Social), the Technology Acceptance Model, and key factors that 
emerged in the literature as important (Autonomy and Privacy) [28-30].  
By using the constructs in the model to identify themes that predict consumer usage in 
technology adoption and health-related behavior, we developed the FG guide, qualitative coding 
code-groups, and theme development. The overall goal of analysis was to gauge the likelihood that 
people would use our DS mHealth app. Full description of the conceptual model and defined 
constructs can be found in Figure 1.  
[Fig. 1] 
Population and Recruitment  
Patient advisory group (PAG) members from multiple departments of an academic 
medical center were recruited into four FGs. To improve participant diversity, additional FGs were 
conducted with members of the general public recruited through ResearchMatch.org. FGs were 
limited to <7 participants per group to enable constructive conversation.  
Data Collection and Analysis  
FGs were led by experienced facilitators (KF, SG) and supported by additional study 
staff. Data were collected via audio recording and supplemental notes. Prior to the start of each 
FG, a consent form was read aloud, and participants were provided with an opportunity to ask 
questions, confirm verbal understanding, and provide verbal consent. Ground rules for respectful 
discussion were established, and participants were cautioned to maintain confidentiality. 
The FG discussion guide included 13 questions with follow-up prompts (see Online 
Resource). Questions included queries about the perception of DS safety and risks, communication 
with providers, and comfort with use of technology. Then we presented a description of a possible 
app design. Participants were - invited to comment on app features, including 1) linking to a 
database dedicated to DS information; 2) bar-code scanning; 3) capture of dose and frequency; and 
4) linking to the EMR. 
To protect privacy, participant names and identifiable information were not recorded. 
Participants provided demographic information including age, gender, race/ethnicity, education, 
and personal DS use. 
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FGs were audio recorded and transcribed verbatim. Qualitative analysis was conducted 
using ATLAS.ti (Version 8, Scientific Software Development GmbH, Berlin, Germany). Team 
members (EP, ZK, KF, CN) generated codes and code groups based on model constructs and 
allowed additional codes to emerge from the transcripts. Two investigators (EP, ZK) 
independently coded each transcript, cross-referenced codes, and made revisions as needed. 
During the final analysis, the team compared codes across all transcripts and condensed into 
existing model constructs or emergent themes (Table S1 in Online Resources). 
Results 
Study Participants 
From August 2019 to June 2020, six FGs (and one interview) were held with a total of 24 
participants [Table 1] [Table 2]. Of the participants, 67% were female, 57% non-Hispanic White, 
and 63% were PAG members. All reported post-secondary education and 88% reported DS use. 
Focus Group Themes 
In the analysis, the following themes were related to or emerged from our model: 1) 
concern about DS safety and inaccurate documentation; 2) advantages of mHealth use; 3) attitudes 
to mHealth use; 4) behavioral intention and use behavior.  
Perceived Threat: Concerns about DS Safety 
 Some participants expressed concern about DS quality and safety, including wariness of DS 
advertisements (e.g., false or misleading information in advertisements). They identified the 
potential for SDIs and highlighted the importance of sharing DS use with their providers: 
“[Supplements] effect the way [drugs] work in your body… It should be particularly concerning if 
you are not sharing that with someone on your team… It needs to get into your medication 
record.”  
Many participants stated concern that their DSs were not properly recorded in the EMR 
due to difficulty entering DSs into the system, insufficient time during visits, or the perceived lack 
of importance of these products by providers. Participants were not always asked about their DS 
use, and even when asked, they were not queried about details:  
“Whenever I go to the physician’s office, they always ask me if I’m taking the 
medications that are on the list, but never ask me if I’m taking any supplements.” 
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“[I don’t] think anything got in there about how long you are taking or how often.”  
They also discussed doctors’ lack of training regarding DSs:  
“I’m very concerned that there's nothing in doctors’ normal training that teaches them to 
understand interactions or benefits or anything having to do with supplements.”  
 
“If [a provider] doesn’t know [DS information] I don’t think she will have the time to look it up to 
see if there’s any interaction”  
 
Perceived Benefits: Advantages to mHealth App Use  
 Perceived advantages of mHealth app use emerged as well. Participants felt an app would 
enhance patient-provider communication by enabling disclosure of DS use to providers, as well as 
free up time in the clinical encounter for meaningful discussion around DS use. They believed the 
app could overcome documentation challenges by ensuring accurate input of the DS brand, dose, 
and frequency, and would empower the patient in taking control of their health. Having access to 
the list on their phone, with appropriate reminders, would ensure the list is always kept up-to-date 
and accurate. Participants shared:  
“It will make it easy for both the patient and the healthcare provider in that the records would be 
in a central place that either one of us can get to.”  
 
“I think that it helps the patient provide more information to [the provider] in a more precise way 
and they can get to information, exact dosage, and name of the [product].”  
 
 Another perceived advantage of the app was its capability of providing reliable DS 
information for both the patient and provider. Participants felt that the app should include readily 
accessible and reliable DS information including existing clinical data, recommended doses, and 
known interactions: “Ideally internal to that app is all of the information about the interaction 
effects of drugs and supplements.”  
  Having readily available and reliable DS information regarding products patients are taking 
would inform patient and provider conversations: “I think it would educate me and inform my 
conversation with my doctor to ask if I should take XYZ at the same time.”  
 Some participants recognized the lack of training about DSs in conventional medicine and 
hoped the app would promote team-based care by enabling communication with providers 
specialized in DSs (e.g., pharmacists, dietitians, naturopathic doctors). Integration into the EMR 
would allow identification of safety concerns, such as inappropriate doses and SDIs, and result in 
improved care: 
“It’ll be easier for [providers] to say, ‘Okay, I see you're taking vitamin D, this milligram is based 
on whatever labs we've done, [and I] want you to increase or decrease,’ it just would make it 
easier for that provider to provide care in general.”  
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Attitudes about mHealth App Use   
 
Autonomy Concerns. Some participants were wary of sharing some DSs, such as the use of 
cannabidiol products, products that replace positive health behaviors (e.g., weight-loss 
supplements to replace a healthy lifestyle), or products for memory enhancement. Participants 
acknowledged they would be hesitant to discuss DSs with providers if they expected disapproval. 
When asked about sharing DS information with a provider, one participant stated:  
“It’s not easy because sometimes they don’t agree with you. I have provided some to my primary 
care provider, however, I did not provide all of them, because there is a hesitation always that 
they don’t believe in this and they don’t believe in that”  
 
 However, some participants were interested in an app that could improve their ability to 
consistently take their DSs and monitor their response: “I would like to use something like this to 
keep track of what I'm taking and how often I'm taking.” Others hoped for maximum flexibility 
regarding reminders and push notifications.   
 
Privacy Concerns. Concerns related to mHealth app use stemmed from overall attitudes about 
technology. Participants expected that the app would include standard HIPAA-compliant security 
features:“If it wasn’t covered under HIPAA, I probably wouldn’t use it.” Participants also were 
wary about receiving unsolicitated advertising as a consequence of a leaked list.  
With the assumption of HIPAA compliant security features, most participants were not 
worried about the privacy of their information, particularly if no other personal health information 
was in the app: 
“I personally would be more concerned with people seeing my prescribed drug list than I would 
with people seeing my dietary supplement drug list.”  
 
 
Technology Access and Self-Efficacy. Access to the technology needed for the app by older or 
lower socioeconomic status (SES) users was a concern: 
“It's not available then to people who are poor and live in rural areas or people who live in public 
housing areas, they just don't have the money to buy that kind of phone, so cost is a barrier.”  
 
Additionally, they were concerned about the technology self-efficacy for people who 
would not be able to navigate the app on their own:“I’m not so sure it would be easy for an elderly 
or aging person who is not already electronically savvy to understand and to be consistent with 
[using the app].” For these users, point-of-care barcode scanning in the provider’s office was 
suggested.  
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Facilitators (Technological Support). A few felt technical facilitators or tech support would be 
necessary to help users navigate the app, while most felt it was not necessary:“It should be easy to 
begin with, [users] shouldn’t have to go to tech support.”  
 
Behavioral Intention and Use Behavior: Factors to Influence mHealth App 
Use 
Effort Expectancy and Performance Expectancy. Participants who regularly took DSs stated 
they would be likely to use the app, whereas those who did not take DSs regularly were less 
inclined. Participants expressed higher likelihood to utilize the app if it possessed key features and 
functionality to meet their individual needs. Almost all of the participants desired the app to 
connect with the EMR, so as to be accessible to both themselves and providers: “I would be likely 
to use it if I knew it would tie into the existing system that my doctor uses.”  
Social Influence. When asked about the impact of support for the app from their doctor, 
participants stated they would use the app regardless of support from their provider if they 
perceived benefit from the app: “I would use it either way and wouldn’t try to push it on the 
doctor but would hope he shows some sort of interest.” 
 
Discussion 
We learned that participants’ views indicating their use behavior of our mHealth app were 
consistent with our conceptual model predicting health-improving and technology adoption 
behavior, although participants weighted some aspects more heavily than others. The most 
important constructs were effort expectancy, self-efficacy, performance expectancy, and perceived 
benefit. Participants desired an app that was easy to use with a user-friendly interface. They were 
more likely to use the app if their baseline technology self-efficacy was high (i.e., they had 
confidence in their ability to navigate the technology) and if they perceived larger potential benefit 
from using the app (i.e., DS users were more likely to use it than non-users).  
Participants expected a desirable app to contain features such as a drug-DS interaction 
checker, access to reliable DS information, and connection to the EMR, while maintaining their 
health autonomy (i.e., allowing them to decide on what they share with the provider). They desired 
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the ability to tailor the app experience to their personal needs (e.g., keep track of their DS list, send 
reminders to take DSs).  
Constructs that did not hold as much weight in participants’ intention to utilize the app 
included privacy and social influence. Participants acknowledged the high prevalence of health 
information housed electronically and expressed no concern using the app if it contained standard 
HIPAA-compliant privacy measures. Although participants preferred support from their provider 
for using the app, they stated that they would continue to use it if they perceived health benefits. 
We found that patients were more likely to be interested in using an mHealth app 
containing the following elements: 1) HIPAA-compliance; 2) ease of use for a variety of technical 
self-efficacy levels; 3) access to reliable DS information, including a DS-drug interaction checker; 
4) integration within the EMR. We believe that, if the app meets the above criteria, patients will 
use it to track and communicate their DSs use with their providers for enhanced DS reconciliation.  
Limitations  
The primary study limitation was the sample population. We were limited in our capacity 
to recruit and speak to a fully diverse population, since we were limited geographically to central 
North Carolina. Our study population predominantly included a higher level of education, and we 
did not speak with many less educated or elderly participants. Persons with the latter demographic 
characteristics are at higher risk for having low technology access and self-efficacy and potentially 
complex medication regimens, and their opinions should be captured. It is possible we would have 
identified additional themes with a more varied population (i.e., we falsely believed we reached 
saturation), and our results may not be generalizable to these populations. However, PAG 
members ensured advocacy for these missing participants and their potential views. PAG members 
specifically brought our attention to the needs of those with lower technology self-efficacy. 
Another study limitation was conducting the last FGs via teleconferencing due to 
COVID-19. Having online FGs, rather than in person, has the potential to limit constructive, 
natural conversation. However, the FGs conducted over Zoom did not seem to limit conversation 
amongst participants compared to our other FGs. 
Conclusions 
Participants believe their DS information is inaccurately represented in the EMR leading 
to safety issues, negatively impacting overall quality-of-care. An mHealth app to simplify and 
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improve DS entry and reconciliation was of interest if it maintained health autonomy and privacy 
and possessed key features and functionality, including: 1) HIPAA compliance; 2) ease of use; 3) 
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Fig. 1 Conceptual model for study of attitudes and intention to use dietary supplement mHealth 
app. Model created on Lucid.app. Ovals describe constructs from the Health Belief Model (HBM): 
Technology Self-Efficacy, Perceived Benefit, and Perceived Threat [28]. Rectangles represent 
original concepts from the Unified Technology Acceptance and Use of Technology (UTAUT) 
model: Facilitators (Technological Support), Effort Expectancy, Performance Expectancy, Social 
Influence, Behavioral Intention, and Use Behavior [27, 30]. Pentagons represent constructs from 
the Technology Acceptance Model (TAM) and Theory of Planned Behavior Model (TBM): 
Perceived Behavioral Control and Attitudes About mHealth Use [30]. Banners are important 
constructs that have emerged through investigations from other researchers: Autonomy 
Concerns and Privacy Concerns [27]. All of the constructs lead to behavioral intention and use 
behavior which is the main goal of our mHealth app development  
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Technology Self-Efficacy Participant?s comfort with using cell phone apps and technology
Perceived Benefit Potential benefit of using the app
Perceived Threat Potential negative consequence of using the app
Facilitators The necessity of having technological support offered with the app
Effort Expectancy How easy the app is to use
Performance Expectancy How the app will perform, including possessing desired features and functionality
Social Influence Influence from healthcare provider, family, and friends regarding using the app
Perceived Behavioral Control The control users perceive that may limit their behavior
Attitudes About mHealth Use How a participant feels about using technology to manage their healthcare
Autonomy Concerns Desire for control over one?s own healthcare
Privacy Concerns Concern over privacy and security of using the app
Behavioral Intention Likeliness of using the app once developed
Use Behavior Participants incorporation of the app into their normal routine
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Table 1 Baseline Demographics and Characteristics of Focus Group Participants  
Characteristic FG Participants 
(N = 24) 
Median age (range) – yr.  57 (28-77) 
Gender – no. (%)  
 Male 8 (33) 
 Female 16 (67) 
Race and ethnicity – no. (%)  
 Non-Hispanic White 14 (58) 
 Non-Hispanic Black, African, or African American 6 (25) 
 Hispanic or Latino 3 (13) 
 Asian 1 (4) 
Highest level of education – no. (%)  
 Grade school, High school, or GED 0 (0) 
 Associate or Technical degree 1 (4) 
 Bachelor’s degree 7 (29) 
 Master’s degree 9 (38) 
 Doctoral degree 7 (29) 
Dietary supplement use – no. (%)  
 Yes 21 (88) 
 No 2 (8) 




Table 2 FG Session Characteristics  
FG # Number of Participants Length of FG FG Conducted via  
1 6 37 min In-person 
2 6 97 min In-person 
3 3 59 min In-person 
4 3 87 min In-person and 
virtual 
5 3 62 min Virtual 
6 1 35 min Virtual 






Focus Group Introduction 
Thank you for taking the time to join this discussion today. My name is Kim and I will be 
the moderator for this focus group. The purpose of this discussion is to gather your opinions 
regarding tracking and reconciliation of dietary supplements. The definition of a dietary 
supplement is, “A product that is intended to supplement the diet. A dietary supplement contains 
one or more dietary ingredients (including vitamins, minerals, herbs or other botanicals, amino 
acids, and other substances) or their components; is intended to be taken by mouth as a pill, 
capsule, tablet, or liquid; and is identified on the front label of the product as being a dietary 
supplement.”  We will discuss the medication reconciliation process during patient visits, and how 
dietary supplements are, or are not, included in that process. For our study, we define medication 
reconciliation as the process of comparing a patient's medication list in their medical chart to the 
medications that the patient has actually been taking. This reconciliation is done to avoid 
medication errors such as omissions, duplications, dosing errors, or drug interactions. 
You will be provided with a $25 gift card for your participation today, and food will be 
provided. 
This focus group is being conducted to support a larger study on improving the 
documentation of dietary supplements in a patient’s chart. Both the focus group and the 
subsequent research study are being conducted by a team of researchers here at the University of 
North Carolina, Chapel Hill. 
Before we start, I would like to remind you that there are no right or wrong answers in 
this discussion. I am interested in knowing what each of you think. Please be honest and share 
what you think, even if you don’t agree with others in the group. It is very important that I hear all 
of your opinions, but you may choose not to answer a question at any time. 
Let's start by going around the circle and have each person introduce themselves. I would 
like each of you to state either a first name or a nickname that you would like to use for the 
discussion. Your name will not be used when we summarize group responses, or in any written 
reports. 
Let’s make a list of rules to guide our discussion today. I would like for us, as a group, to 
agree that what is shared here today stays within our group. In other words, to make sure that 
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everyone feels comfortable sharing their opinions, I want us to agree that we will not talk about 
what we discuss today with people who were not in this group. We have a few other ground rules 
to cover, and let me know if you have any others that you would like to add. 
Ground Rules  
• Everything we talk about today is private  
• Use first names or nicknames only when referring to other participants 
• There are no right or wrong answers 
• It is important that we respect everyone’s opinions, even if they are different from our 
own 
• We want to hear from everyone 
Can we as a group agree on these ground rules?  Would you like to add any other ground rules?  
Do you have any questions before we begin recording the discussion?  Does everyone agree to 
having the recorder turned on? 
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Focus Group Discussion Guide 
1. Do you think it is common for people to use dietary supplements, such as vitamins, 
minerals, herbal supplements, or food-based supplements? 
a. Follow-up: Which type of supplements do you think are most commonly used? 
2. Do you think supplements can affect the way medications work in the body? 
a. Follow-up: How concerned are you about the risks associated with dietary 
supplements, particularly those your healthcare provider does not know you are 
taking? 
3. Do you think it is important for a person’s care team, including their physician, to know if 
they are using supplements? 
a. Follow-up: How do you feel about sharing information about your dietary 
supplement use with your provider? 
b. Follow-up: Do you think it is a hard thing for people to discuss with their 
provider? 
c. Follow-up: Are there health habits you would not want to share?  
4. How well do you think healthcare providers document supplement information in a 
patient’s medical chart (reconciliation)? 
a. Follow-up: If not well, why might the information be inaccurate? 
b. Follow-up: Do you think it is hard for healthcare providers to keep track of 
patient’s supplement use? Why or why not? 
Now we will ask questions about our proposed mobile application. We anticipate creating an app 
that people can use at home to document their dietary supplements. The app would enable them to 
scan the supplement barcode and create a list that could be shared with their provider or uploaded 
into the electronic health record. (Show diagram) 
5. How comfortable are you with cell phone apps in general? 
6. Do you think it would be helpful to have mobile app that scans a supplement’s barcode?  
a. Follow-up: As described, how easy do you think the app might be to use? 
b. Follow-up: What might it easier to use? 
c. Follow-up: What barriers do you see to using the app? 
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7. How important do you think it would be to have tech support to help you figure out how 
to use the app? 
a. Follow-up: How important would tech support be to troubleshoot with you if 
there are problems? 
8. What do you think the dietary supplement mHealth app could do for you? 
a. Follow-up: How can the process of documenting supplement use in a patient’s 
chart be easier for patients and healthcare providers? 
9. How do you think your healthcare provider will feel about you use of dietary supplement 
app to share your supplement list? 
10. How concerned would you be about privacy in using the app? 
a. Follow-up: How would you feel if your dietary supplement information was 
shared without your knowledge? 
11. If the dietary supplement app were available today, how likely would you be to use it? 
a. Follow-up: Why or why not? 
12. How do you feel about the proposed dietary supplement app? 
a. Follow-up: What would an ideal mobile app for users of dietary supplements 
look like to you? 
13. Is there anything else you would like to add regarding collection of medication and 
dietary supplement information? 
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Table S1 Codebook from Data Analysis  








Why people use DS Anxiety 
Beauty 
Beliefs about health and disease 
Cancer 






Health promotion  
Memory loss 
Pain 
Side effects of conventional medicines 
Sleep trouble/disturbance/insomnia 
Substitute for behavior/lifestyle change 
Substitute for medication  
Supplement availability  
Supplementing diet 
Weight lifting/muscle building 
Weight loss 
Safety/Threat of DS Adverse effects and DS-Disease interaction 
Beliefs about doctors 
Concern about supplement quality and safety  
Drug/supplement interactions 
Uncertainty about effects  
Wariness of advertising  
Autonomy Desire for control of health 
Patient willing to discuss diet/lifestyle  
Patient willing to discuss DS use with provider 
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Reluctance to discuss DS 
Performance Expectancy Barcode scanning 
Connect to EMR 
Drug-supplement interaction checker 
General 
Notes 
Perceived overall value 
Reliable DS info 
Reminders  
Effort expectancy Effort expectancy/ease of app use 
Tech Self-Efficacy General 
Use of barcode scanner 
Tech self-efficacy by age or SES  
Technical facilitators of app use  
Potential App Benefit Communicating DS with provider 
Doctors’ lack of training regarding DS 
Doctors’ reluctance to discuss DS 
DS documentation challenges  
DS/medication recommendations 
Impact on clinical visit 
Improved/holistic care 
Lack of knowledge regarding DS 
Perceived benefit 
Providers specialized in DS 
Potential App Harm Cell phone connection and storage 
Cumbersome process 
Notifications/reminders  
Privacy related to app use 
Tech access by age or SES 
Unintended consequences 
Social Influence Friends, family, Internet recommended DS 
Provider asks about DS 
Provider disapproves of DS 
Provider doesn’t ask about DS  
Provider recommends DS 
Provider support for app 
Behavioral Intention Behavioral intention/likeliness of app use 
 
 
